login
login

Europe Daily Bulletin No. 12835

19 November 2021
Contents Publication in full By article 21 / 31
EU RESPONSE TO COVID-19 / Health
European Medicines Agency could approve GSK's Covid-19 treatment within two months

18/11/2021 (Agence Europe)The European Medicines Agency (EMA) announced on Thursday 18 November that it had started to evaluate an application made for marketing authorisation for the Covid-19 treatment candidate Xevudy (sotrovimab), developed by the British company GSK in collaboration with the American company Vir biotechnology. This monoclonal antibody is intended for the treatment of adults and adolescents who do not require supplemental oxygen therapy, but are at an increased risk...

Contents

SECTORAL POLICIES
ECONOMY - FINANCE - BUSINESS
INSTITUTIONAL
EXTERNAL ACTION
EU RESPONSE TO COVID-19
SOCIAL AFFAIRS - EDUCATION
NEWS BRIEFS